Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Levofloxacin,Helicobacter pylori - second line use,Levofloxacin,Recommended for decline,Community and Hospital,Alimentary Tract and Metabolism
